UCLA Commences Study of New Treatment Strategy for Human Papilloma Virus (HPV) related Head and Neck Cancer.
Details about this clinical trial >
New Clinical Trial Uses Novel Treatment for Early Stage (Stage I or II), Inoperable Lung Cancer - A newly recruiting UCLA study for Inoperable, Early-Stage (Stage I or II) Lung Cancer. Details about this clinical trial >
Dr. Amar Kishan, 2018 Radiation Oncology Institute Publication Award Recipient - The award recognizes the best scientific work published in the past year that has had a lasting impact in the field of radiation oncology.
Article newsroom.ucla.edu > | Story on roinstitute.org >